Endometrial Disorder Clinical Trial
Official title:
Endometrial Volume as a Predictor of Endometrial Pathology in Perimenopausal Uterine Bleeding Endometrial Volume as a Predictor of Endometrial Pathology in Perimenopausal Uterine Bleeding
Endometrial thickness has been used as an indicator of risk for endometrial hyperplasia and carcinoma in asymptomatic perimenopausal women. However, there is no cutoff value in perimenopausal women and the same thickness does not express the same endometrial volume in different endometrium because uterine lengths may be different and endometrial irregularities may exist. Many studies assessed endometrial volume measured by three-dimensional (3D) TVS as a predictor of malignancy in women with postmenopausal bleeding. To our knowledge there is no study assess endometrial volume measured by two dimension TVS in prediction of endometrial pathology, however it is cheap and available than 3D TVS.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04454749 -
Endometrial Compaction and Its Influence on Pregnancy Rate in Frozen Embryo Cycle Regimes
|
||
| Completed |
NCT01805115 -
Misoprostol Administration Before Operative Hysteroscopy
|
Phase 3 | |
| Completed |
NCT04363879 -
Comparing Two Types of Endometrial Activation Prior to Embryo Transfer
|
N/A | |
| Recruiting |
NCT03067623 -
Autologous Platelet-Rich Plasma (PRP) and Endometrial Thickness
|
Phase 2 | |
| Not yet recruiting |
NCT05157373 -
The Effect of Androgen Receptor Polymorphism on Endometrial Cancer
|